Jerry Y. Hsu

3.1k citations
43 papers · 2.3k indexed · 1 hit paper · h-index 17
Topics
PI3K/AKT/mTOR signaling in cancer (15 papers)Advanced Breast Cancer Therapies (12 papers)Cancer Treatment and Pharmacology (11 papers)
Journals
CellJournal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations
United StatesSpainCanada

In The Last Decade

Jerry Y. Hsu

39 papers receiving 2.3k citations

Hit Papers

The lore of the RINGs: substrate recognition and catalysi...20002026200820172000100200300400500

Peers

Jerry Y. Hsu
Comparison fields: 5 of 99
  • Molecular Biology 1.8k
  • Cell Biology 777
  • Oncology 723
  • Pulmonary and Respiratory Medicine 373
  • Epidemiology 208
Replace Grzegorz Nalepa with:
Grzegorz Nalepa United States
Frauke Schimmöller United States
Marc R. Mansour United Kingdom
Sylvie Giuriato France
Olle Sangfelt Sweden
Seth Sadis United States
Shunsuke Nakagawa Japan
Andrew Wilber United States
Panayotis Zacharatos Greece
Ute Schaeper Germany
Jerry Y. Hsu relative to Grzegorz Nalepa United States Grzegorz Nalepa's profile →
Citations per field
00.5×3.8×
Grzegorz Nalepa · 1×
Citations per year

Countries citing papers authored by Jerry Y. Hsu

Since Specialization
Citations

This map shows the geographic impact of Jerry Y. Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry Y. Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry Y. Hsu more than expected).

Fields of papers citing papers by Jerry Y. Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry Y. Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry Y. Hsu. The network helps show where Jerry Y. Hsu may publish in the future.

Co-authorship network of co-authors of Jerry Y. Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry Y. Hsu. A scholar is included among the top collaborators of Jerry Y. Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry Y. Hsu. Jerry Y. Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 2
5 0
6 3
7 5
8 12
9 116
10 1
11 1
12 57
13 105
14 120
15 7
16 115
17 2
18 43
19 284
20
The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligasesbreakdown →
532

About Jerry Y. Hsu

Jerry Y. Hsu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cell Biology, having authored 43 papers that have together received 2.3k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (15 papers), Advanced Breast Cancer Therapies (12 papers) and Cancer Treatment and Pharmacology (11 papers). The work is most often cited by research in Cell Biology (777 citations), Oncology (723 citations) and Molecular Biology (1.8k citations). Jerry Y. Hsu has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Peter K. Jackson, Julie D.R. Reimann, Ellen Freed, Brett K. Kaiser, Adam G. Eldridge, Heather A. Wakelee, Jan‐Michael Peters, Edgar R. Kramer, Claus Storgaard Sørensen and Alexander V. Loktev. Their work appears in journals such as Cell, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026